Academic Journal

The sodium channel blocker RS100642 reverses down-regulation of the sodium channel α-subunit Na 1.1 expression caused by transient ischemic brain injury in rats.

Bibliographic Details
Title: The sodium channel blocker RS100642 reverses down-regulation of the sodium channel α-subunit Na 1.1 expression caused by transient ischemic brain injury in rats.
Authors: Yao, C., Williams, A., Lu, X., Price, R., Cunningham, B., Berti, R., Tortella, F., Dave, J.
Superior Title: Neurotoxicity Research; Jun2003, Vol. 5 Issue 4, p245-253, 9p
Abstract: In this study we evaluated the expression of five sodium channel (NaCh) α-subunit genes after transient middle cerebral artery occlusion (MCAo) in the rat and the effects of treatment with the NaCh blocker and experimental neuroprotective agent RS100642 as compared to the prototype NaCh blocker mexiletine. The expression of Na 1.1, Na 1.2, Na 1.3, Na 1.7, Na 1.8 and the housekeeping gene β-actin were studied in vehicle or drug-treated rats at 6, 24 and 48 h post-MCAo using real-time quantitative RT-PCR. RS100642 (1 mg/kg), mexiletine (10 mg/kg), or vehicle (1 ml/kg) was injected (i.v.) at 30 min, 2, 4, and 6 h post-injury. Following MCAo only the Na 1.1. and Na 1.2 genes were significantly down-regulated in the ipsilateral hemisphere of the injured brains. RS100642 treatment significantly reversed the down-regulation of Na 1.1 (but not Na 1.2) at 24-48 h post-injury. Mexiletine treatment, on the other hand, had no significant effect on the down-regulation of either gene. These findings demonstrate that treatment with a neuroprotective dose of RS100642 significantly reverses the down-regulation of Na 1.1 caused by ischemic brain injury and suggests that RS100642 selectively targets the Na 1.1 α-subunit of the NaCh. Furthermore, our findings strengthen the hypothesis that ischemic injury may produce selective depletion of voltage-gated NaChs, and suggest that the Nav 1.1 NaCh α-subunit may play a key role in the neuronal injury/recovery process. [ABSTRACT FROM AUTHOR]
Copyright of Neurotoxicity Research is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Complementary Index
Description
Description not available.